ProQR to host a conference call to discuss the top-line results of the Phase 2/3 Illuminate clinical trial of investigational RNA therapy sepofarsen in CEP20-mediated LCA10.
… and therapeutic formulations for research and clinical development. Location: Leiden (on-site) The Role: … tech transfer, and campaign execution to support clinical trials, and regulatory submissions. The person hired …
Featuring Dr. Byron Lam, Professor, Bascom Palmer Eye Institute, University of Miami School of Medicine
Hosted by Cantor Biotechnology Analysts Emma Nealon, Alethia Young